Medical Properties Trust, Inc. common stock (MPT)

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced that Infracore SA (“Infracore”), the Swiss hospital real estate company in which MPT currently owns a 70% non-controlling interest, is expected to list its shares on the SIX Swiss Exchange following its previously announced initial public offering in Switzerland. The per share price of the initial listing of CHF 54.00, which values Infracore’s equity market capitalization at CHF 826 million, is approximately 5% higher than MPT’s pro rata carrying value.

MPT (the “Company” or “MPT”) (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on July 16, 2026, to stockholders of record on June 18, 2026.

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the first quarter ended March 31, 2026, as well as certain events occurring subsequent to quarter end.

MPT (the “Company” or “MPT”) (NYSE: MPT) today announced it will host a conference call and webcast on Thursday, April 30, 2026, at 11:00 a.m. Eastern Time to discuss the Company’s first quarter 2026 financial results. A press release with the first quarter 2026 financial results will be issued before the market opens on April 30, 2026.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) investors concerning the Company’s possible violations of the federal securities laws.

Law Offices of Howard G. Smith continues its investigation on behalf of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz continues its investigation of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) investors concerning the Company’s possible violations of the federal securities laws.

Law Offices of Howard G. Smith announces an investigation on behalf of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) investors concerning the Company’s possible violations of federal securities laws.

The Law Offices of Frank R. Cruz announces an investigation of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) on behalf of investors concerning the Company’s possible violations of federal securities laws.

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today issued the following statement regarding litigation involving Healthcare Systems of America (“HSA").

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2025, as well as certain events occurring subsequent to quarter end.

MPT (the “Company” or “MPT”) (NYSE: MPT) today announced that its Board of Directors declared a regular quarterly cash dividend of $0.09 per share of common stock to be paid on April 9, 2026, to stockholders of record on March 12, 2026.

MPT (the “Company” or “MPT”) (NYSE: MPT) today announced it will host a conference call and webcast on Thursday, February 19, 2026, at 11:00 a.m. Eastern Time to discuss the Company’s fourth quarter and year-end 2025 financial results. A press release with the fourth quarter 2025 financial results will be issued before the market opens on February 19, 2026.